Jeremy Bahr is a principal at Leavitt Partners. Jeremy’s work focusses on developing solutions that intersect value and strategy within the life sciences sector. Jeremy is a key leader with our private equity, data and analytics and technology clients. He helps oversee key strategic engagements—building brands, delivering insights, and leading business transformations.
Jeremy has more than two decades of global experience leading change and driving growth in life sciences companies. Before joining Leavitt Partners, Jeremy ran his own consulting business, serving clients in pharma, health tech, data and analytics, and private equity. Prior to his consulting work, Jeremy was the Chief Business Officer of Photocure—the Bladder Cancer Company, responsible for global branding and marketing, corporate strategy, and business development. Previously, Jeremy was Vice President at UCB Pharma where he led Commercial Data and Analytics globally and the Commercial Operations team in North America. He also spent many years in senior roles at Pfizer, leading large teams in marketing, sales, strategy, innovation, and analytics.
Early in his career, Jeremy spent five years as a consultant at McKinsey and Company where he focused on growth strategy in high tech and biotech companies and was a member of McKinsey’s Marketing, Private Equity, and Healthcare practices. He also served clients in retail, CPG, finance, energy, and manufacturing. At different times, Jeremy has also been an entrepreneur, venture capital investor, and worked in government, education, and non-profits.
Jeremy earned his master’s degree in Business Administration from the Harvard Business School. Jeremy earned two bachelor’s degrees from Brigham Young University, in molecular biology and political science.